Chemerin and CMKLR1 expression in human arteries and periadventitial fat: a possible role for local chemerin in atherosclerosis?

Chemerin reduces vascular nitric oxide/cGMP signalling in rat aorta: a link to vascular dysfunction in obesity?

(2014) Karla Bianca Neves et al.   CLINICAL SCIENCE

Increased Chemerin and Decreased Omentin-1 in Both Adipose Tissue and Plasma in Nascent Metabolic Syndrome

(2013) Ishwarlal Jialal et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Serum chemerin levels are associated with the presence and extent of coronary artery disease

(2012) Li Xiaotao et al.   CORONARY ARTERY DISEASE

Chemerin as a Mediator between Obesity and Vascular Inflammation in Children

(2012) Kathrin Landgraf et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Expression, Regulation, and Function of Atypical Chemerin Receptor CCRL2 on Endothelial Cells

(2012) J. Monnier et al.   JOURNAL OF IMMUNOLOGY

The Chemerin/ChemR23 System Does Not Affect the Pro-Inflammatory Response of Mouse and Human Macrophages Ex Vivo

(2012) Benjamin Bondue et al.   PLoS One

Chemerin/ChemR23 signaling axis is involved in the endothelial protection by KATP channel opener iptakalim

(2011) Rui-jun Zhao et al.   ACTA PHARMACOLOGICA SINICA

Vascular Effects of Novel Adipocytokines: Focus on Vascular Contractility and Inflammatory Responses

(2011) Hideyuki Yamawaki   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Association of chemerin mRNA expression in human epicardial adipose tissue with coronary atherosclerosis

(2011) Xiuying Gao et al.   Cardiovascular Diabetology

Adipoparacrinology – vascular periadventitial adipose tissue (tunica adiposa) as an example

(2011) George N Chaldakov et al.   CELL BIOLOGY INTERNATIONAL

Perivascular adipose tissue: more than just structural support

(2011) Theodora Szasz et al.   CLINICAL SCIENCE

Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism

(2011) Benjamin Bondue et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Elevated Serum Chemerin Levels are Associated with the Presence of Coronary Artery Disease in Patients with Metabolic Syndrome

(2011) Baokang Dong et al.   INTERNAL MEDICINE

Adipokines in Periaortic and Epicardial Adipose Tissue: Differential Expression and Relation to Atherosclerosis

(2011) Sofia G. Spiroglou et al.   Journal of Atherosclerosis and Thrombosis

Adipose Tissue, Inflammation and Atherosclerosis

(2011) Birgit Gustafson   Journal of Atherosclerosis and Thrombosis

Circulating Chemerin Level is Independently Correlated with Arterial Stiffness

(2011) Hye Jin Yoo et al.   Journal of Atherosclerosis and Thrombosis

Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features

(2011) Gianluca Iacobellis et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Aspirin-Triggered Lipoxin and Resolvin E1 Modulate Vascular Smooth Muscle Phenotype and Correlate with Peripheral Atherosclerosis

(2010) Karen J. Ho et al.   AMERICAN JOURNAL OF PATHOLOGY

Perivascular adipose tissue as a cause of atherosclerosis

(2010) Sandra N. Verhagen et al.   ATHEROSCLEROSIS

Identification of chemerin receptor (ChemR23) in human endothelial cells: Chemerin-induced endothelial angiogenesis

(2010) Jaspreet Kaur et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The role of epicardial and perivascular adipose tissue in the pathophysiology of cardiovascular disease

(2010) D. Margriet Ouwens et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Chemerin Contributes to Inflammation by Promoting Macrophage Adhesion to VCAM-1 and Fibronectin through Clustering of VLA-4 and VLA-5

(2010) R. Hart et al.   JOURNAL OF IMMUNOLOGY

Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis

(2009) Michael Lehrke et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY